1. Ho, K.J. (1995). Urinary β glucuronidase in screening and follow up of primary urinary tract malignancy. J. Urol. 154 (4), 1348–1350.
2. Ho, K.J. and Kuo, S.H. (1995). Urinary β glucuronidase activity as an initial screening test for urinary tract malignancy in high risk patients: comparison with conventional urine cytological evaluation. Cancer 76 (3), 473–478.
3. Karmowski, A., Sobiech, K.A., Majda, J.M., Karmowski, M., Blok, K., Madej, P. and Malik, B. (2003). Lysosomal hydrolases activity in serum and urine of patients undergoing surgery for uterine myomas III β glucuronidase (BGR) Pol. J. Gynaecol. Invest. 5 (3), 333–338.
4. Glucuronidase, Beta: http://www.worthington-biochem.com/GL/default.html.
5. Harvey, S.R., Ambaye, R.Y. and Panse, T.B. (1966). Kinetics of β glucuronidase and its evaluation in oral cancer. Ind. J. Med. Science, 20, 381–387.